Brief: Biosergen Q3 EBITDA Loss Narrows To SEK 7.5 Mln
30/11/2023 11:07
Nov 30 (Reuters) - Biosergen AB BIOSGN.ST :
* Q3 EBITDA LOSS SEK 7.5 MILLION VERSUS LOSS SEK 14.5
MILLION YEAR
AGO
Source text for Eikon: ID:nWkr7VNnLr
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million